Chittorgarh.com Logo
Loading...

Windlas Biotech IPO Details

IPO Open Aug 4, 2021
IPO Close Aug 6, 2021
IPO Price ₹460
Face Value ₹5
IPO Size ₹401.54 Cr
Listing At BSE, NSE
Lot Size 30
Open an Instant Account with Zerodha
  1. Windlas Biotech IPO: Retails investors lead charge, issue subscribed 7.06 times on Day 2

    Sep 28, 2022 3:30:00 AM

    Windlas Biotech shares were trading at a premium of Rs 110-130 in the grey market, translating to 23.9-28.3 percent premium over the issue price of Rs 460, the IPO Watch and IPO Central data shows.

    Publish by : moneycontrol.com
  2. Windlas Biotech, Exxaro Tiles IPOs Subscription Status Day 1: How was the investors response? Know here

    Aug 5, 2021 7:18:00 PM

    Four initial public offerings (IPO) -- Windlas Biotech, Exxaro Tiles, Krsnaa Diagnostics and Devyani International -- have opened for subscription from Wednesday. Windlas Biotech's IPO was subscribed ...

    Publish by : Zee Business
  3. Windlas Biotech Ltd (WINL)

    Oct 3, 2022 1:31:00 PM

    Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

    Publish by : Investing
  4. IPOs this week: 4 companies coming up with their IPOs on August 4—check issue size, price band, market lot and KEY DATES

    Aug 2, 2021 8:39:00 AM

    IPO This Week: Devyani International IPO, Exxaro Tiles IPO, Krsnaa Diagnostics IPO and Windlas Biotech IPO will be opned for subscription on August 4. Zomato, Tatva Chintan Pharma Chem Limited, GR ...

    Publish by : Zee Business
  5. Which VCs Are Poised to Profit From the Biotech IPO Boom?

    Sep 9, 2022 3:30:00 AM

    and that biotech IPOs have done exceptionally well of late. “The phone is ringing now,” Blair says, with LPs checking references on venture capitalists. He predicts that some of the VC firms ...

    Publish by : Xconomy
  6. Are Biotech IPOs Coming Back? Some Investors Think So

    Sep 18, 2022 5:30:00 PM

    recent acquisitions of biotechs, and strong clinical-trial data from several drugmakers are whetting investor appetite, which will likely lead to more IPOs, investors and analysts say.

    Publish by : Wall Street Journal
  7. Listen: Pharma’s telehealth gold mine, the return of the biotech IPO, & a merger deferred

    Sep 15, 2022 3:30:00 AM

    We also discuss the White House’s investment in biotech, a bellwether IPO, and the latest twist in the Merck-Seagen saga. Biotech Startups and Venture Capital Reporter Allison is a biotech ...

    Publish by : STAT
  8. Curative Biotechnology files for NYSE American uplisting, $8M IPO

    Sep 30, 2022 6:39:00 PM

    The company added that it intends to conduct a 1-for-400 reverse stock split ahead of the IPO. Curative Biotechnology's shares are currently traded OTC under the symbol CUBT. The company has ...

    Publish by : Seeking Alpha
  9. Cambridge biotech files for IPO, six months after public launch

    Aug 25, 2022 3:49:00 AM

    Natalie Holles is the CEO of Third Harmonic Bio. A Cambridge biotech startup may break the monthslong lull in the local IPO market, just six months after its public launch. Third Harmonic Bio ...

    Publish by : The Business Journals
  10. Gene Therapy Biotech Prime Medicine Begins U.S. IPO Effort

    Sep 28, 2022 12:52:00 AM

    Prime Medicine (PRME) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement. The firm is a pre-clinical stage biopharma developing genetic ...

    Publish by : Seeking Alpha
  11. Which VCs Are Poised to Profit From the Biotech IPO Boom?

    Sep 9, 2022 3:30:00 AM

    But this is shaping up to be the year the storyline changes, thanks to the ripple effect from the biotech IPO class of 2013. It’s still too early to say that biotech VCs have climbed all the way ...

    Publish by : Xconomy

Windlas Biotech IPO Alerts

1. Windlas Biotech IPO Listing Date & Info  Friday, August 13, 2021 6:09:00 AM

The IPO Shares of Windlas Biotech Limited IPO are proposed to list on Monday, August 16, 2021 at BSE, NSE. The public issue of Windlas Biotech IPO was opened on Aug 4, 2021 and closed for subscription on Aug 6, 2021. Windlas Biotech IPO Listing Date and Information:

Windlas Biotech Limited Listing Date

Listing DateMonday, August 16, 2021
BSE Script Code543329
NSE SymbolWINDLAS
Listing In
ISININE0H5O01029
Issue Price₹460 Per Equity Share
Face Value₹5 Per Equity Share

2. Windlas Biotech IPO Allotment Status  Wednesday, August 11, 2021 7:30:05 PM

The allotment status of Windlas Biotech Limited IPO is now available online. The public issue of Windlas Biotech IPO was open on Aug 4, 2021 and closed for subscription on Aug 6, 2021. The equity shares of the company to be list at BSE, NSE.

3. Windlas Biotech IPO Closes on Aug 6, 2021  Thursday, July 29, 2021 1:14:11 AM

The issue of Windlas Biotech Limited opens on Aug 4, 2021 and closes for subscription on Aug 6, 2021. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs 448- Rs 460 Per Equity Share.

4. Windlas Biotech IPO Opens on Aug 4, 2021  Thursday, July 29, 2021 1:13:42 AM

Windlas Biotech Limited is entering in the capital market with an IPO of [.] Equity Shares of Rs 5 aggregating up to Rs 401.54 Crore. The price for the issue has been set at Rs 448-460 Rs Per Equity Share.

Incorporated in 2001, Windlas Biotech Ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organizations (CDMO) segment in India. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.

The issue opens on Aug 4, 2021 and closes for subscription on Aug 6, 2021. The equity shares of the company to be list at BSE, NSE.

Windlas Biotech IPO News & Events FAQs

The Windlas Biotech IPO is proposed to open on Aug 4, 2021. The IPO application ends on Aug 6, 2021.

Retail investors can apply in the retail or non-institutional investor category from Aug 4, 2021 to Aug 6, 2021. The Windlas Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The Windlas Biotech IPO will open for subscription on Aug 4, 2021. The public issue will close on Aug 6, 2021.